Nano-X Imaging Ltd. (NNOX) Insider Trading Activity

NASDAQ$0.2873-0.02 (-6.55%)
Market Cap
$24M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
248 of 849
Rank in Industry
41 of 107

NNOX Insider Trading Activity

NNOX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$182,856
7
88
Sells
$1,119
1
12

Related Transactions

Suesskind Dan Sdirector
2
$91,800
0
$0
$91,800
Meltzer ErezChief Executive Officer
4
$61,356
0
$0
$61,356
Kainan Nogadirector
1
$29,700
0
$0
$29,700
Alroy Erezdirector
0
$0
1
$1,119
$-1,119

About Nano-X Imaging Ltd.

Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and …

Insider Activity of Nano-X Imaging Ltd.

Over the last 12 months, insiders at Nano-X Imaging Ltd. have bought $182,856 and sold $1,119 worth of Nano-X Imaging Ltd. stock.

On average, over the past 5 years, insiders at Nano-X Imaging Ltd. have bought $93,253 and sold $1,119 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Suesskind Dan S (director) — $91,800. Meltzer Erez (Chief Executive Officer) — $61,356. Kainan Noga (director) — $29,700.

The last purchase of 25,000 shares for transaction amount of $11,250 was made by Meltzer Erez (Chief Executive Officer) on 2026‑10‑19.

List of Insider Buy and Sell Transactions, Nano-X Imaging Ltd.

2026-10-19PurchaseMeltzer ErezChief Executive Officer
25,000
0.0349%
$0.45
$11,250
-19.49%
2026-09-15PurchaseMeltzer ErezChief Executive Officer
10,000
0.0144%
$0.69
$6,900
-21.72%
2026-09-14PurchaseSuesskind Dan Sdirector
60,000
0.0925%
$0.76
$45,300
-21.14%
2026-08-10PurchaseMeltzer ErezChief Executive Officer
9,443
0.0131%
$1.03
$9,726
-34.98%
2026-07-28PurchaseKainan Nogadirector
33,000
0.0486%
$0.90
$29,700
-16.81%
2026-07-27PurchaseSuesskind Dan Sdirector
50,000
0.0754%
$0.93
$46,500
-17.49%
2026-07-27PurchaseMeltzer ErezChief Executive Officer
36,000
0.0543%
$0.93
$33,480
-17.49%
2026-06-10SaleAlroy Erezdirector
678
0.001%
$1.65
$1,119
-45.94%
2025-09-05PurchaseDaniel RanCFO
1,000
0.0019%
$3.65
$3,650
-34.15%
Total: 9
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Suesskind Dan Sdirector
110000
0.14%
$33,594.0020
Meltzer ErezChief Executive Officer
90443
0.1151%
$27,621.2940
Kainan Nogadirector
40792
0.0519%
$12,457.8810
Daniel RanCFO
6950
0.0088%
$2,122.5310
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$9,837,727
35
7.68%
$94.71M
$1,105,104
34
-11.40%
$311.25M
$20,867,362
27
-3.90%
$467.11M
$58,749,198
24
16.21%
$100.45M
$842,771
15
6.44%
$214.28M

NNOX Institutional Investors: Active Positions

Increased Positions59+48.36%4M+35.2%
Decreased Positions49-40.16%801,036-6.34%
New Positions19New3MNew
Sold Out Positions17Sold Out313,385Sold Out
Total Postitions132+8.2%16M+28.86%

NNOX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.